TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Sequent Scientific Limited ( (IN:SEQUENT) ) has issued an update.
Sequent Scientific Limited and Viyash Lifesciences Private Limited have received approval from the National Company Law Tribunal for their merger, marking a significant transformation in the global animal health market. This merger is expected to create a leading animal health company from India, leveraging synergies to enhance financial performance and capitalize on growth opportunities in the companion animal health segment and the genericization of animal health products. The merger aims to accelerate organic growth, provide financial stability, and enhance capabilities in research and development, positioning the combined entity as a reliable partner in the industry.
More about Sequent Scientific Limited
Sequent Scientific Limited is a prominent player in the global animal health industry, focusing on providing innovative solutions for animal care. The company is involved in the production of pharmaceuticals for animals, with a strong emphasis on research and development to enhance its product offerings.
Average Trading Volume: 90,367
Technical Sentiment Signal: Buy
Current Market Cap: 57.53B INR
For a thorough assessment of SEQUENT stock, go to TipRanks’ Stock Analysis page.